Ramzi Aboujaoude, MD
Obstetrics & Gynecology · Richmond, VANPI 1093911802
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,943 of the $9,810 with a category attached, or 70.8%. 25 manufacturers reported payments, led by Caldera Medical, Inc at 35.4% of the total. Reporting peaked in 2019 at $2,833 and has fallen 72.3% since, to $784 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $59.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Caldera Medical, Inc$3K
- Intuitive Surgical$2K
- Boston Scientific$1K
- Axonics, Inc.$765
- Sumitomo Pharma America, Inc.$510
- Medtronic$464
- plus $2K from 19 others
Across 80 payments — averaging $1058.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$85K
What the payments were for
- Travel & lodging$1,40714%
- Food & beverage$6,94371%
- Education$3273%
- Gifts$1,13312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Caldera Medical, Inc | 37 | $3,470 |
| Intuitive Surgical | 8 | $1,857 |
| Boston Scientific | 14 | $1,117 |
| Axonics, Inc. | 10 | $765 |
| Sumitomo Pharma America, Inc. | 30 | $510 |
| Medtronic(2 entities) | 8 | $464 |
| Astellas Pharma US Inc | 14 | $457 |
| AbbVie(2 entities) | 13 | $399 |
| Coopersurgical, Inc. | 3 | $169 |
| Bluewind Medical | 1 | $115 |
| Avion Pharmaceuticals | 6 | $71 |
| Conmed Corporation | 1 | $67 |
| Mayne Pharma Commercial LLC | 6 | $64 |
| Coloplast | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $38 |
| Biogen | 2 | $37 |
| Exeltis, USA Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Mimedx Group, Inc. | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Pfizer | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Desara$2,367
- Da Vinci Surgical System$1,771
- UPSYLON$619
- Bulkamid$367
- INTERSTIM$223
- Vertessa$218
- BOTOX$121
- REVI$115
- GENERAL - THERAPIES$109
- Axonics$101
How this compares
$9,810 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 200 | $146,878 |
| MyrbetriqMirabegron | 191 | $137,295 |
| Solifenacin Succinate | 297 | $19,204 |
| Mirabegron ErMirabegron | 30 | $18,821 |
| Estradiol | 184 | $12,580 |
| YuvafemEstradiol | 68 | $8,092 |
| NitrofurantoinNitrofurantoin Macrocrystal | 265 | $5,106 |
| Trimethoprim | 95 | $3,698 |
| Oxybutynin Chloride ErOxybutynin Chloride | 85 | $1,884 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 169 | $1,642 |
| Clobetasol Propionate | 25 | $1,479 |
| Fosfomycin Tromethamine | 18 | $978 |
| Raloxifene Hcl | 14 | $721 |
| Metronidazole | 21 | $686 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 36 | $484 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $510 | $146,878200 claims |
| Astellas Pharma US IncMyrbetriq | $457 | $137,295191 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Richmond
- James JonesRichmond$134K
- Nicole KarjaneRichmond$34K
- Lauren SiffRichmond$16K
- Christina IsaacsRichmond$11K
- Frances CaseyRichmond$11K
- Karen KnappRichmond$9K
- Victoria DavisRichmond$6K
- Adrienne MaraistRichmond$6K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.